Search
Now showing items 11-20 of 30
A comparative bioavailability of four carbamazepine tablet formulations available in the Kenyan market
(1996)
The relative bioavailabilities of three carbamazepine tablet formulations available in the Kenyan market (Temporal", Taver" and Carbamazepine Lincoln) compared with the innovator formulation (Tegretol") were evaluated in ...
Evaluation of tetracycline raw materials and finished products found on the kenyan market
(1994)
Contents of tetracycline, its degradation products (epitetracycline, epianhydrotetracycline, anhydrotetracycline) and a fermentation impurity (2-acetyl-2-decarboxamidotetracycline) were determined in four raw materials, ...
The neutralizing capacity and sodium content of antacid brands on the Kenyan market
(1995)
Seventeen brands of antacid products available on the Kenya market were investigated for their acid neutralising capacity and sodium content Thirteen tablet products gave neutralising capacity per tablet of between 4.7 to ...
Quality performance of metronidazole tablet products on the Kenyan market
(1991)
The in vitro performance of metronidazole tablet product by different manufacturers avallable on the Kenyan market was evaluated. It was found that a number of generic metronidazole tablet products have quality performance ...
In Vitro evaluation of Carbamazepine 200g tablets. East African Medical Journal Vol. 70 (8): 512-514
(University of Nairobi, 1993)
No abstract available
Specialization in Pharmacy Practice
(University of Nairobi, 1991)
The community Pharmacist
(University of Nairobi, 1993)
Microbial contamination of oral dosage forms.
(University of Nairobi, 1996)
No abstract available
Quality of intravenous infusion fluids manufactured in Kenya: E.Afr. Med. J. 72 (12) :800-804)
(University of Nairobi, 1995)
The incidence and nature of microbial contamination of intravenous fluids prepared by four manufacturing establishments in Kenya was evaluated using the European Pharmacopoeia membrane filtration method for sterility ...
An overview of quality control in the pharmaceutical industry in Kenya. 4(3): 55-57
(University of Nairobi, 1992)
No abstract available